BrightSpring Health Services, Inc. BTSG 深 滬
等待開盤 11-04 09:30:00 美东时间
69.84
+3.580
+5.40%
華盛通- 最 高70.00
- 今 開66.50
- 成交量 417.36万股
- 最 低 66.26
- 昨 收 66.26
- 總市值 138.97亿
- 52周最高 73.7499
- 市盈率 靜 80.50
- 換手率 2.10%
- 52周最低 30.64
- 委 比 -56.86%
- 總股本 1.99亿
- 歷史最高 73.7499
- 量 比 1.11
- 振 幅 5.64%
- 歷史最低 7.85
- 每 手 1
- 風險率 12.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 苹果、雅诗兰黛、莱迪思半导体均获大行上调目标价
今日重点评级关注：Rosenblatt：维持SiTime"买入"评级，目标价从750美元升至900美元；花旗：维持Madrigal Pharmaceuticals"买入"评级，目标价从725美元升至760美元
今天 18:17
美股大行评级 | 潜在涨幅2250.23%！艾伯维获大摩等多家大行上调目标价，最高340美元
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从50美元升至51美元；HC Wainwright & Co.：上调伊诺维奥制药评级至"买入"，目标价5美元
11-03 18:20
Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $82
Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $78 to $82.
11-02 21:51
美股盘前 | BrightSpring Health Services, Inc.上升7.94%，Rocket上升6.46%
BrightSpring Health Services, Inc.上升7.94%；Rocket上升6.46%；再生元制药公司上升6.24%
11-02 16:11
财报速睇 | BrightSpring Health Services, Inc. 2026财年Q3营收42.13亿美元，同比增长26.4%；归母净利润1.00亿美元，同比增长79.3%
华盛资讯10月30日讯，BrightSpring Health Services, Inc.公布2026财年Q3业绩，公司Q3营收42.13亿美元，同比增长26.4%，归母净利润1.00亿美元，同比增长79.3%。
10-30 18:32
BrightSpring Health Q3 Adj. EPS $0.54 Beats $0.47 Estimate, Sales $4.213B Beat $3.875B Estimate
BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.47 by 14.89 percent. This is a 80 percent increase over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $4.213 billion ...
10-30 18:04
BrightSpring Health Raises FY2026 Sales Guidance from $15.100B-$15.425B to $15.900B-$16.125B vs $15.346B Est
BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $15.100 billion-$15.425 billion to $15.900 billion-$16.125 billion vs $15.346 billion estimate.
10-30 18:00
美股盘后 | Franco-Nevada小升2.36%，BrightSpring Health Services, Inc.小升2.00%
Franco-Nevada小升2.36%；BrightSpring Health Services, Inc.小升2.00%；TKO Group Holdings小升2.00%
08-29 06:10
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
